NEW YORK (Reuters Health) – An intraocular lens made of a photoreactive silicone material can be adjusted using ultraviolet irradiation after being implanted following cataract removal, providing individual…
NEW YORK (Reuters Health) – Despite tradeoffs in visual acuity, patients with ocular melanoma near the optic nerve benefit from proton beam radiotherapy in terms of eye conservation…
NEW YORK (Reuters Health) – Some patients with primary open-angle glaucoma benefit from more frequent visual field testing, according to results of a study published online August 8…
NEW YORK (Reuters Health) – Despite changes in the flora responsible for microbial keratitis, second-generation fluoroquinolone monotherapy remains the empirical treatment of choice, researchers from the UK report…
NEW YORK (Reuters Health) – Resolution of pain and inflammation after cataract surgery is faster when patients are treated once a day with bromfenac ophthalmic solution, according to…
NEW YORK (Reuters Health) – As a first-line operation for primary open-angle glaucoma, insertion of a Molteno drainage tube provides better control of intraocular pressure (IOP) than does…
NEW YORK (Reuters Health) – After six monthly intraocular injections of ranibizumab (Lucentis; Genentech) for macular edema, the benefits are maintained for another 6 months when ranibizumab is…
NEW YORK (Reuters Health) – Retinal videos are just as effective as standard still retinal images for detecting diabetic retinopathy, according to results of a comparative study of…
NEW YORK (Reuters Health) – In a head-to-head trial, latanoprost proved to be noninferior to timolol in the treatment of glaucoma in children, according to a report in…
NEW YORK (Reuters Health) – Using intra-arterial chemotherapy to treat retinoblastoma can produce a “dramatic response,” but also comes with the risk of both mild and severe side…